A Phase 3 interventional study of 10 valent pneumococcal conjugate vaccine and Infanrix Hexa in Infections, Rotavirus, sponsored by GlaxoSmithKline. Completed at 10 sites in Czech Republic. Open to participants aged 9 Weeks to 16 Weeks, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-03-23.
Sponsored by GlaxoSmithKline · Phase 3, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies testing RIX4414 vaccine in Rotavirus Infections — none open to participants now, none under way, none of them phase 3. RIX4414 vaccine · Rotavirus Infections.
Among the 19 studies testing RIX4414 vaccine in Rotavirus Infections, this one is the 12th largest by enrollment, is the only one that started in 2006, is one of 9 in phase 3, and was the 4th registered.
104 studies on the registry are indexed under Rotavirus Infections; 3 are open to participants now.
Browse Rotavirus Infections studies →None of the 19 studies testing RIX4414 vaccine in Rotavirus Infections is open now. The open studies under Rotavirus Infections, anywhere →
No approval found in the FDA or EMA files read. How studies give it is on its page →
Of the 3 Rotavirus Infections studies recruiting now, none set no upper age limit and 3 stop at 75 or younger; 3 take children under 18; 3 take healthy volunteers.
This study: 9 Weeks to 16 Weeks · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 1 started in 2006.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 400 is close to the median of 403 across 69 interventional studies indexed under Rotavirus Infections.
Median enrollment 472 across the 19 interventional studies. Of the 19 that completed or were terminated, 12 (63%) have results posted.
This tab as a report to print or save as PDF → With an account.
17 of 19 have an industry lead sponsor. The 3 most frequent:
GlaxoSmithKline is the lead sponsor of 3,652 studies on the registry; 118 are open to participants now.
Of its 267 completed or terminated interventional studies of FDA-regulated products, 241 (90%) have results posted.
61 studies in Rotavirus Infections by GlaxoSmithKline: none open now, none under way, none of them phase 3. Of 59 finished, 21 (36%) have results posted.
Among the 61 studies in Rotavirus Infections by GlaxoSmithKline, this one is the 24th largest by enrollment of the 38 interventional ones that give a count, is one of 7 that started in 2006, is one of 23 in phase 3, and was the 13th registered.
GlaxoSmithKline’s Rotavirus Infections studies by the year they started, since 2000.
None of the studies under way reaches primary completion within a year.
Among the 19 studies testing RIX4414 vaccine in Rotavirus Infections, from their registry updates:
Nothing recorded among them since 2026-09-25.
Among GlaxoSmithKline’s 61 in Rotavirus Infections:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this trial is to assess if the rate of febrile reactions following the co-administration of pneumococcal conjugate vaccines with standard infant vaccines is lowered when paracetamol is given prophylactically.
2 groups (200 per group); control group receives no prophylactic antipyretic treatment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Also known as: Rotarix, Infanrix Hexa, 10 valent pneumococcal conjugate vaccine
Occurrence of fever > or = to 38°C (rectal temperature)
Safety, reactogenicity and immunogenicity pre and post-vaccination
Plan to share: Yes — Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.
The record gives a start of Sep 2006 and a completion of Apr 2007. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine · RIX4414 vaccine · Acetaminophen